skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A hypoxia-inducible factor (HIF)-3α splicing variant, HIF-3α4 impairs angiogenesis in hypervascular malignant meningiomas with epigenetically silenced HIF-3α4

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [1]; ;  [1]; ;  [2];  [3];  [4]; ;  [5];  [1]
  1. Department of Neurosurgery, Nagoya University School of Medicine, Nagoya (Japan)
  2. Department of Biomolecular Engineering, Tokyo Institute of Technology Graduate School of Bioscience and Biotechnology, Yokohama (Japan)
  3. National Center for Geriatrics and Gerontology, Aichi (Japan)
  4. Department of Neurosurgery, Fukushima Medical University School of Medicine, Fukushima (Japan)
  5. MICRON Inc.Medical Facilities Support Department, Aichi (Japan)

Highlights: ► HIF-3α4 is silenced by DNA methylation in meningiomas. ► Induction of HIF-3α4 impaired angiogenesis in meningiomas. ► Induction of HIF-3α4 impaired proliferation and oxygen-dependent metabolism. -- Abstract: Hypoxia inducible factor is a dominant regulator of adaptive cellular responses to hypoxia and controls the expression of a large number of genes regulating angiogenesis as well as metabolism, cell survival, apoptosis, and other cellular functions in an oxygen level-dependent manner. When a neoplasm is able to induce angiogenesis, tumor progression occurs more rapidly because of the nutrients provided by the neovasculature. Meningioma is one of the most hypervascular brain tumors, making anti-angiogenic therapy an attractive novel therapy for these tumors. HIF-3α has been conventionally regarded as a dominant-negative regulator of HIF-1α, and although alternative HIF-3α splicing variants are extensively reported, their specific functions have not yet been determined. In this study, we found that the transcription of HIF-3α4 was silenced by the promoter DNA methylation in meningiomas, and inducible HIF-3α4 impaired angiogenesis, proliferation, and metabolism/oxidation in hypervascular meningiomas. Thus, HIF-3α4 could be a potential molecular target in meningiomas.

OSTI ID:
22239532
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 433, Issue 1; Other Information: Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions
Journal Article · Fri Apr 26 00:00:00 EDT 2013 · Biochemical and Biophysical Research Communications · OSTI ID:22239532

HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma
Journal Article · Sun Feb 01 00:00:00 EST 2015 · Experimental Cell Research · OSTI ID:22239532

Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein
Journal Article · Sun Sep 01 00:00:00 EDT 2013 · Toxicology and Applied Pharmacology · OSTI ID:22239532